Home
overview

Asthma and COPD together create an enormous public health burden and an urgent need for progress in disease understanding, therapy and care. Join us at SMi's 11th annual Asthma & COPD conference to share in the experiences of leading lights in the field who are addressing the challenges of solving the riddle of pathogenesis, biomarkers and endpoints, personalising therapies vs. the unmet need, tackling the causes and consequences of exacerbations, development of new animal models and better tools for disease diagnosis and monitoring.

This conference will give delegates invaluable insights into the key thinking and advances in the respiratory drug market, focusing on the challenges and solutions to enhance patient outcomes, providing extensive knowledge from the key leading industry, academic and care providing experts.

 

• Explore the future of asthma and COPD treatment from a range of key perspectives
• Discover advances in inhaled therapies
• Discuss personalised therapy approaches, asthma patient stratification and unmet needs
• Share in the latest thinking from the clinic to improve the lives of patients
• Explore the latest thinking on biomarkers and clinical trial endpoints
• Update on mechanisms and treatment for viral induced COPD and asthma exacerbations
 

   

Chief Executives, Chief Scientific Officers, Chief Medical Officers, Vice Presidents, Heads, Directors, Senior Scientist, Principle Scientists, Clinicians, Physicians, Project Leaders, Specialists, and Managers in the following areas:


• Respiratory Physiology & Medicine
• Respiratory Pharmacology
• Regulatory and Medical Affairs
• Inflammatory Disease
• Respiratory, Inflammation and Autoimmunity
• Pulmonary Disease
• Respiratory Therapeutics
• Immunology
• Medical & Inhalation Devices
• In-Vitro Biology
• Biomarker • Inflammation Discovery
• Preclinical R&D
• Clinical Pharmacology
• Clinical Trials
• Research and Development
• Business Development
• Brand Manager
• Commercial
• Respiratory
 

3M Health Care; 3M Healthcare Limited; Abbott; Almirall; Argenta Discovery Ltd; Astra Zeneca; AstraZeneca; AstraZeneca R&D Mölndal; BioMed Central; Biomedical Systems; British Lung Foundation; Carclo Technical Plastics Ltd; Chiesi Farmaceutici S. P. A. ; Chiesi Farmaceutici SpA; Early Clinical Development; F. Hoffmann-La Roche Ltd.; Fidelta; Glenmark Pharmaceutials; GSK; Hvidovre Hospital University of Copenhagen; Imperial College Of Science And Medicine; Lisa Tan Consulting; Medicines Assessment; MedImmune; MHRA; National Heart and Lung Institute Imperial College London; National Jewish Health South Denver; Newcastle University; Novartis Horsham Research Centre; Orion Pharma; Private Practice ; Sandoz International Gmbh; Sanofi; SkyePharma AG; Synairgen Ltd; Teva UK Ltd; Therachallenges; Theravance, Inc; University Of Southampton School Of Medicine; Vectura; Verona Pharma; Zentiva; Zentiva Group, a.s.; Zentiva Inhalationsprodukte GmbH;

Conference programme

8:30 Registration & Coffee

9:00 Chairman's Opening Remarks

Sebastian Johnston

Sebastian Johnston, Professor of Respiratory Medicine, National Heart and Lung Institute, Imperial College London

9:10 Children’s asthma treatments are like children’s clothes: make sure they fit

Andrew Bush

Andrew Bush, Professor of Paediatric Respirology, Imperial College London and Royal Brompton Hospital

• Severe asthma in children is pathophysiologically different to the adult disease
• Before reaching for the monoclonal, think: are the basics right?
• When assessing results: did they CONSORT with the right children
• Planning trials: does the cap fit?

9:40 Unravelling mechanisms of asthma exacerbations and implications for the future

Sebastian Johnston

Sebastian Johnston, Professor of Respiratory Medicine, National Heart and Lung Institute, Imperial College London

• Aetiology of asthma exacerbations
• Deficient antiviral immunity in asthma
• Epithelial immune interactions in asthma exacerbations
• Implications for new therapies

10:10 Morning Coffee

10:40 Is neutrophilic/non-eosinophilic inflammation an appropriate therapeutic target in asthma?

Neil C Thomson

Neil C Thomson, Professor of Respiratory Medicine, University of Glasgow

• Which inflammatory phenotype to target: non-eosinophilic, neutrophilic, Th2-low?
• Trials and tribulations with licensed drugs including macrolides for treating neutrophilic/non-eosinophilic asthma
• Novel small molecules for treating neutrophilic/non-eosinophilic asthma
• Potential role for biological agents for treating neutrophilic/non-eosinophilic asthma

11:10 Mechanisms mediating paediatric severe asthma: translational approaches

Sejal  Saglani

Sejal Saglani, Reader in Respiratory Paediatrics , Imperial College London

• Pathology of paediatric severe asthma: inflammation and remodelling
• Steroid responsiveness in severe disease
• Novel therapeutic targets
 

11:40 Cytokine regulation of pulmonary inflammation and remodelling in asthma

Clare Lloyd

Clare Lloyd, Professor of Respiratory Immunology, Imperial College London

• Can asthma phenotypes be modelled in vivo?
• Is airway remodelling dependent on inflammation?
• How do genes and environment affect development of pathology?
• Novel therapeutic avenues
 

12:10 Networking Lunch

13:10 Changing role of patient charities in research – what can we offer?

Samantha Walker

Samantha Walker, Executive Director, Research & Policy, Asthma UK

• Benefits of working with charities to patients and wider society
• What value can patient charities bring to multi-partner collaborations?
• The Asthma UK approach to establishing research partnerships with industry
• Examples of large collaborative research programmes that Asthma UK is involved in and future ways of working

 

13:40 Enabling targeted therapy for severe asthma through molecular phenotyping and biomarker development

Joseph Arron

Joseph Arron, Associate Director, Biomarker Discovery, Genentech, Inc.

• Asthma heterogeneity impacts target, patient, and outcome selection
• A clinically valid biomarker comprises both the thing being measured and the assay used to measure it
• How to prove biomarker selection hypotheses in clinical studies
• Beyond type 2 inflammation: new insights into asthma phenotypes

14:10 New therapeutic approaches for asthma: It’s all about the airways

Dirk Smith

Dirk Smith, Scientific Director , Amgen

• New biology is emphasizing the importance of the epithelium and innate immune pathways as key orchestrators of asthma-associated pathology
• What clues have genetics provided regarding key pathways and risk factors?
• Asthma is not a single disease- the importance of stratification and biomarkers
• Emerging targets and biomarker approaches from the new science

14:40 Eosinophilic inflammation and exacerbations of asthma and COPD: A fatal liaison

Roland  Kolbeck

Roland Kolbeck, Respiratory, Inflammation & Autoimmunity, MedImmune

• Management of acute exacerbations in Asthma and COPD
• The role of eosinophilic inflammation in Asthma and COPD
• Development of monoclonal antibodies for the management of severe Asthma and COPD
• The need for personalized health care
 

15:10 Afternoon Tea

15:40 Asthma and COPD phenotypes – how reliable are they?

Mona Bafadhel

Mona Bafadhel, Senior Lecturer Respiratory Medicine & NIHR Post-Doctoral Fellow, University Of Oxford

• Learning from cluster analyses
• Evidence for stable phenotypes
• Impact on therapy
 

16:10 The ADEPT study: airways disease endotyping for personalised therapeutics in asthma and COPD

Philip E Silkoff

Philip E Silkoff, Senior Director, Immunology, Pulmonary Disease Area, Janssen Inc

• It’s clear not all drugs work in all people; are you surprised?
• Janssen wished to build up an internal database for asthma and COPD to interrogate current and future therapeutic targets
• We recruited 150 asthmatics and 30 healthy controls in PART 1 and 60 COPD and 60 healthy controls in Part 2. Most subjects had bronchoscopies
• We have already gained great insights and the analysis has only just begun!
 

16:40 Chairman’s Closing Remarks and Close of Day One

Sebastian Johnston

Sebastian Johnston, Professor of Respiratory Medicine, National Heart and Lung Institute, Imperial College London

8:30 Registration & Coffee

9:00 Chairman's Opening Remarks

Robert Niven

Robert Niven, Senior Lecturer in Respiratory Medicine, University of Manchester

9:10 Ceramide 1-phosphate (C1P), a potential new therapeutic target for COPD

Antonio Gomez-Munoz

Antonio Gomez-Munoz, Professor of Biochemistry and Molecular Biology, University of the Basque Country

• C1P reduces lung inflammation
• C1P promotes cell growth, survival and migration
• The mechanism whereby C1P exerts its anti-inflammatory actions involve inhibition of sphingomyelinase and serine palmitoyl transferase activities, reduction of pro-inflammatory cytokines, and inhibition of NF-kB
• C1P analogs are promising tools for developing new strategies to treat COPD

9:50 Viruses in asthma and COPD

Patrick Mallia

Patrick Mallia, Senior Clinical Lecturer, Imperial College London

• Contribution of viruses to exacerbations in asthma and COPD
• Mechanisms of virus-induced exacerbations
• Viral/bacterial co-infection
• Future developments

10:20 Drug development challenges associated with inhaled and intranasal antivirals

Staffan Edsbacker

Staffan Edsbacker, Global Project Director and Associate Professor , AstraZeneca R&D Mölndal and University of Lund

• Device and dosing considerations
• Indication and patient segmentation
• Trial setting and endpoints
 

10:50 Morning Coffee

11:20 Round Table Discussion: Challenges and choices in stratified asthma therapeutics

Robert Niven

Robert Niven, Senior Lecturer in Respiratory Medicine, University of Manchester

  • How many interleukin targeting MABS will be enough?
  • What are the unmet needs in asthma and what is the future for these groups?
  • 11:50 Always on, always with you. The role of personal technology and the digital economy in respiratory health

    • Why will we see increasingly widespread adoption of new personal health technologies?
    • There’s an app for that: medical “apps” are likely to have a significant role in respiratory health in the future
    • Google knows, do you? The trail left by your daily interactions contains valuable health related data
    • Discuss examples of smart devices (including smart inhalers) providing information that isn’t apparent to healthcare professionals
     

    John Blakey

    John Blakey, Senior Clinical Lecturer, Liverpool School of Tropical Medicine

    James Pinchin

    James Pinchin, Research Fellow, Horizon DERC, The University of Nottingham

    12:30 Networking Lunch

    13:30 RPL554 as a novel treatment for severe COPD

    Jan-Anders Karlsson

    Jan-Anders Karlsson, CEO , Verona Pharma

    • Unmet medical need in COPD
    • RPL554 as a treatment of COPD exacerbations
    • Additional potential indications for RPL554
     

    14:30 Afternoon Tea

    15:00 Pulmonary rehabilitation in the real world

    Maria Buxton

    Maria Buxton, Consultant Respiratory Physiotherapist , London North West Healthcare NHS Trust

    • Research vs Real Life
    • Drop out – is there an answer?
    • Mapping PR in London
    • Commissioning PR
     

    15:30 COPD: Unmet need and challenges in NHS Care

    John Hurst

    John Hurst, Consultant in Respiratory Medicine, University College London

    • What are the key areas of unmet clinical need for COPD clinical care?
    • What are the barriers to access for new drugs in current NHS practice?
    • Who is prescribing new drugs in the NHS?
    • Which aspects of COPD urgently require new pharmaceutical approaches?

    16:00 Chairman’s Closing Remarks and Close of Day Two

    +

    FEATURED SPEAKERS

    Andrew Bush

    Andrew Bush

    Professor of Paediatric Respirology, Imperial College London and Royal Brompton Hospital
    Joseph Arron

    Joseph Arron

    Associate Director, Biomarker Discovery, Genentech, Inc.
    Neil C Thomson

    Neil C Thomson

    Professor of Respiratory Medicine, University of Glasgow
    Robert Niven

    Robert Niven

    Senior Lecturer in Respiratory Medicine, University of Manchester

    Andrew Bush

    Professor of Paediatric Respirology, Imperial College London and Royal Brompton Hospital
    Andrew Bush

    Antonio Gomez-Munoz

    Professor of Biochemistry and Molecular Biology, University of the Basque Country
    Antonio Gomez-Munoz

    Clare Lloyd

    Professor of Respiratory Immunology, Imperial College London
    Clare Lloyd

    Dirk Smith

    Scientific Director , Amgen
    Dirk Smith

    James Pinchin

    Research Fellow, Horizon DERC, The University of Nottingham
    James Pinchin

    Jan-Anders Karlsson

    CEO , Verona Pharma
    Jan-Anders Karlsson

    John Blakey

    Senior Clinical Lecturer, Liverpool School of Tropical Medicine
    John Blakey

    John Hurst

    Consultant in Respiratory Medicine, University College London
    John Hurst

    Joseph Arron

    Associate Director, Biomarker Discovery, Genentech, Inc.
    Joseph Arron

    Kirsten Kaiser

    Executive Vice President Medical & Regulatory Development, SkyePharma AG
    Kirsten Kaiser

    Maria Buxton

    Consultant Respiratory Physiotherapist , London North West Healthcare NHS Trust
    Maria Buxton

    Mona Bafadhel

    Senior Lecturer Respiratory Medicine & NIHR Post-Doctoral Fellow, University Of Oxford
    Mona Bafadhel

    Neil C Thomson

    Professor of Respiratory Medicine, University of Glasgow
    Neil C Thomson

    Patrick Mallia

    Senior Clinical Lecturer, Imperial College London
    Patrick Mallia

    Philip E Silkoff

    Senior Director, Immunology, Pulmonary Disease Area, Janssen Inc
    Philip E Silkoff

    Robert Niven

    Senior Lecturer in Respiratory Medicine, University of Manchester
    Robert Niven

    Roland Kolbeck

    Respiratory, Inflammation & Autoimmunity, MedImmune
    Roland  Kolbeck

    Samantha Walker

    Executive Director, Research & Policy, Asthma UK
    Samantha Walker

    Sebastian Johnston

    Professor of Respiratory Medicine, National Heart and Lung Institute, Imperial College London
    Sebastian Johnston

    Sejal Saglani

    Reader in Respiratory Paediatrics , Imperial College London
    Sejal  Saglani

    Staffan Edsbacker

    Global Project Director and Associate Professor , AstraZeneca R&D Mölndal and University of Lund
    Staffan Edsbacker

    Sponsors and Exhibitors

    Official Media Partner

    Supporters

    Attendee List for Asthma & COPD

    Download

    Quick Fire Q&A with Janssen pulmonary disease specialist

    Download

    A spotlight on Asthma & COPD with Joseph Arron, Genentech

    Download

    Sponsors and Exhibitors


    Artimmune

    Sponsors and Exhibitors
    http://www.artimmune.com

    ArtImmune is a contract research company which offers consulting and preclinical research services in immunology and inflammation with an emphasis on lung diseases. ArtImmune has a strong expertise in preclinical investigations of lung functions in vivo including plethysmography, bronchoalveolar lavage, cytology, histology, immunohistochemistry, and analysis of biochemical, immunological and molecular parameters.

    Media Partners


    BioMed Central - COPD Research and Practice

    Official Media Partner
    http://www.copdrp.com/

    BioMed Central is an online STM publisher of more than 270 peer-reviewed open access journals. The portfolio of journals spans all areas of biology, biomedicine and medicine, with many journals publishing content related to pulmonary medicine and allergy research. Examples of such journals include: COPD Research and Practice, Multidisciplinary Respiratory Medicine, Respiratory Research, and Allergy, Asthma & Clinical Immunology. All original research articles published by BioMed Central are made freely accessible online immediately upon publication. Authors publishing with BioMed Central retain copyright of their work, licensing it under the Creative Commons Attribution License which allows articles to be re-used and re-distributed without restriction, as long as the original work is correctly cited. BioMed Central is owned by Springer Science+Business Media, and also hosts the SpringerOpen platform.


    BioMed Central - Respiratory Research

    Official Media Partner
    http://respiratory-research.com/

    Respiratory Research is an open access journal aiming at publishing high-quality science in all areas of respiratory disease. Topics of specific interest include asthma, chronic obstructive pulmonary disease, cystic fibrosis, genetics, infectious diseases, interstitial lung diseases, lung development, lung tumors, occupational and environmental factors, pulmonary circulation, pulmonary pharmacology and therapeutics, respiratory immunology, respiratory physiology, and sleep-related respiratory problems.


    BioMed Central - Cough

    Official Media Partner
    http://www.coughjournal.com/

    Cough is an open access, peer-reviewed, online journal encompassing the scientific and clinical aspects of both acute and chronic cough.


    BioMed Central - BMC Pulmonary Medicine

    Official Media Partner
    http://www.biomedcentral.com/bmcpulmmed

    BMC Pulmonary Medicine is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of pulmonary and associated disorders, as well as related molecular genetics, pathophysiology, and epidemiology.


    BioMed Central - Asthma Research and Practice

    Official Media Partner
    http://www.asthmarp.com/

    Asthma Research and Practice will publish articles related to basic asthma research, clinical practice as well as translational research. The journal aims to publish the most recent and relevant information on asthma and related disorders (such as rhinitis, COPD overlapping syndrome, sinusitis).

    Media Partners


    PharmCast

    Supporters
    http://www.PharmCast.com

    www.PharmCast.com is the world leading website designed specifically for pharmaceutical, clinical and biotechnology professionals. www.PharmCast.com brings up-to-date information on pharmaceutical patents, FDA, news, jobs and Buyer's Guide to our visitors. It was created and is maintained by pharmaceutical and biotechnology professionals. Visit www.PharmCast.com and discover for yourself why it is so popular among professionals.


    British Pharmacological Society

    Supporters
    http://www.bps.ac.uk

    The British Pharmacological Society (BPS) is the primary UK learned society concerned with research into drugs and the way they work. Our members work in academia, industry, regulatory agencies and the health services, and many are medically qualified. The Society covers the whole spectrum of pharmacology, including laboratory, clinical, and toxicological aspects. Clinical pharmacology is the medical speciality dedicated to promoting safe and effective use of medicines for patient benefit. Clinical pharmacologists work as consultants in the NHS and many hold prominent positions in UK Universities.


    Contract Biotechnology

    Supporters
    http://www.contract-biotechnology.com

    Contract-Biotechnology.com is a web-based platform for laboratory outsourcing solutions. We are an online R&D matching tool that connects Scientifics and organizations involved in discovery, development and delivery of new healthcare products with service and products providers worldwide. Life science information technology is undergoing a revolution. Part of that revolution involves new, unexplored business models, open innovation, open data and collaboration. If you have a project or idea that you would like to propose, develop or run, we can help. A New Collaboration Network Model for Discovery Research and Development • Effective Platform: the 95% • 5.000 registered users // > 15.000 Newsletter subscribers • Geographical background: 45,5% Europe / 37,5% North America / 16,5% Asia / 0,5% ROW • Professional background: Outsourcing Manager, Project Manager, CEO, Business Developer, CSO, Account Manager, Sales & Marketing People, Scientists, R&D. For further information, please visit our website www.contract-biotechnology.com


    Gate2Biotech

    Supporters
    http://www.gate2biotech.com

    Gate2Biotech is a portal that unites biotechnological community in Central Europe. It covers all the news in the field of biotechnology. Thanks to the the portal the companies engaged in the field can easily search for research institutions and other partners to solve technical problems they are facing and here they can also present their services offer to potential partners from the Czech Republic and abroad. Gate2Biotech portal serves as a bridge connecting scientific and commercial sector. It incorporates offices and support organizations dedicated to promoting transfer of innovative technologies into a unified communication platform of Czech and international biotechnologies. As a mediator of information it draws attention to biotechnologies and support of their application and transfer into practice. It also functions as a tool for encouraging non-professionals (especially scientists and students) towards innovative business or applied research.


    PharmaVOICE

    Supporters
    http://www.pharmavoice.com

    PharmaVOICE magazine, and its supporting VIEW publications, provide commentary about the challenges and trends impacting the life-sciences industry, covering a range of issues from molecule through market. PharmaVOICE's more than 41,000 U.S.-based subscribers are also kept abreast of the latest trends through additional media resources, including WebSeminars, Podcasts, Videocasts, and White Papers.


    Mednous

    Supporters
    http://www.MedNous.com

    MedNous is a print publication and website about medical innovation in Europe. It carries exclusive interviews with companies that are at the forefront of medical technology, as well as contributor articles from prominent practitioners. Our mission is to identify significant advances in medicine and to explain how this innovation is being commercialised. In doing so, we talk to venture capitalists about what products and platforms they are supporting. We report on how regulators cope with the accelerating pace of innovation. And we regularly cover the latest developments in the discovery and development of new medical concepts in the area of antibodies, vaccines, small molecules, regenerative medicine and nanomedicines. MedNous combines the English word for medicine with the Greek word for intellect. And those with nous are readers of our publication. Visit our website: www.mednous.com


    Drug Development Technology

    Supporters
    http://www.drugdevelopment-technology.com

    Drugdevelopment-technology.com covers every aspect of the drug development and research process, from conception to pre-FDA approval. Our global network of journalists updates the site with the latest and most significant industry developments. This coverage allows us to provide everyone - from senior management through to research and QA staff – with in-depth reviews of the latest projects, advance notice of new product releases and analysis of the latest procedural and legislative developments.


    LabRoots

    Supporters
    http://www.labroots.com/

    LabRoots is a free, social networking site that enables scientists, engineers, and other technical professionals to connect, collaborate with, and learn from each other. LabRoots fosters world-wide scientific communication and incorporates the newest social networking technologies. LabRoots allows scientists to connect with each other as they describe their research interests on a myriad of unique features and tools, discovering meaningful collaborations across geographic boundaries and fields of expertise.


    SelectScience

    Supporters
    http://www.selectscience.net/register?utm_source=Media-Partner&utm_medium=Website&utm_campaign=SMI

    SelectScience is an independent, online information resource for the worldwide scientific community, and the home of trusted information for laboratory scientists. Discover the latest drug discovery and development technologies, products and techniques with product reviews, videos, application notes and news articles. Become a member for free today.


    Pharmaceutical Technology

    Supporters
    http://www.pharmaceutical-technology.com

    Pharmaceutical-technology.com is the only website focusing specifically on issues relevant to pharmaceutical professionals working with technology, be it development, engineering, IT or production. Pharmaceutical-technology.com brings you the latest in industry projects and updates, along with the news, views and trends that leading professionals – from senior executives to manufacturing managers and heads of procurement – require to stay on top of their field.


    Pharmavision

    Supporters
    http://www.pharmavision.co.uk

    PharmaVision offers a consultancy service providing independent pharmaceutical thematic research to the healthcare industry, the investment community and competitive intelligence specialists. We perform due diligence research and provide expert commentary in healthcare. Our reports combine scientific analysis in drug delivery, R&D technologies and pharmaceutical products including patient modelling, product/technology forecasts and market trends evaluation.


    Cutting Edge

    Supporters
    http://www.cuttingedgeinfo.com

    Cutting Edge Information provides customized research and benchmarking reports to pharmaceutical, biotechnology and other life science companies. We provide off-the-shelf and customized research for key areas including medical affairs, clinical development, market access, regulatory affairs, marketing management, sales and HCP fair market value.


    CanBiotech

    Supporters
    http://www.canbiotech.com

    CanBiotech - A Portal and B2B Outsourcing Marketplace for the Biotech and Pharmaceutical Industry. The Marketplace features the Outsourcing Services Showcase; the Portal features our biopharmaceutical and venture capital directories and databases. Publications include the BioMedical Outsourcing Report and the Bio Outsourcing Asia© Publication.


    Technology Networks

    Supporters
    http://www.technologynetworks.com

    Founded in 2000, Technology Networks is established as the leading news provider for life science and drug discovery professionals. In addition, we provide unique content including webcasts, videos, application notes and posters from recent conferences. Our portfolio now includes around 30 focussed scientific communities, all of which are accessible free of charge within TechnologyNetworks.com


    Labsave

    Supporters
    http://www.labsave.com

    Labsave is the leading savings website for Laboratory Equipment and Lab Supplies. We work closely with the top suppliers in the world to bring you the best products at the most competitive prices. We are constantly striving to secure the biggest and most exclusive offers that you won’t find anywhere else! http://www.labsave.com/


    Medical News Today

    Supporters
    http://www.medicalnewstoday.com

    Medical News Today is the largest independent medical and health news site on the web - with over 10,000,000 monthly unique users it is ranked number one for medical news on all major search engines. Medical News Today is used by pharmaceutical, biotech and health organizations, advertising agencies, PR companies and vertical ad networks to deliver targeted campaigns to HCPs, patients and caregivers. To find out how Medical News Today can help you to reach the right audience contact peter@medicalnewstoday.com or visit www.medicalnewstoday.com.


    World Pharma Today

    Supporters
    http://www.worldpharmatoday.com



    KONGPOSH Publications

    Supporters
    http://www.kppub.com

    KONGPOSH Publications is one of India’s leading Pharma Publishers. The Pharma Review® is a bi-monthly article based journal covering various fields of pharmacy. Participation and distribution in over 30 Expos & Conferences worldwide each year. It is widely read by decision makers, middle management and the academia. Also available in E-book format. Other publications : Indian Pharma Reference Guide (Annual) – Names and address of Pharmaceuticals, Bulk Drugs, Machinery’s & Instrumentation, AYUSH Manufacturers; and much more; High Performance Thin Layer Chromatography; Elements of Pharmacovigilance; Regulation of Clinical Trials; AYUSH (CD); NDDS/AMD (CD)


    Genetic Engineering News

    Supporters
    http://www.genengnews.com

    Genetic Engineering & Biotechnology News (GEN) is the most authoritative and widely read biotechnology news publication in the world.Published 21 times a year,GEN's unique news and technology focus include the entire bioproduct life cycle from early-stage R&D to applied research and bioprocess through to commercialization. GEN is the only publication that provides the full range of the biotechnology market coverage in areas such as omics, drugs and biomarker discovery, bioprocessing, clinical research, molecular diagnostics and biobusiness. For a free subscription go to: http://www.genengnews.com/subscriptions.aspx


    Farmavita

    Supporters
    http://www.farmavita.net/

    Farmavita Net is professional community and network of pharmaceutical licensing and business development executives, innovators and researchers
    Farmavita.Net is the pharmaceutical licensing, technology transfer and regulatory affairs network. We are managing the marketplace of offers and demand for pharmaceutical Dossiers, know-how and technologies. Members of Farmavita.Net network usually find a number of attractive solutions for business development, alliances, joint ventures, co-development and co-marketing of pharmaceutical products. Farmavita.Net is not just a pure Internet portal. We manage a number of regional associates. We are connecting the dynamic network of few hundreds members / pharmaceutical companies interested in license-in and license-out opportunities.


    Pharmiweb

    Supporters
    http://www.pharmiweb.com

    Established in October 2003, PharmiWeb Solutions is an energetic, innovative provider of web-based solutions for the pharmaceutical sector, with customers such as AstraZeneca, Roche, Servier Laboratories, and Merck With solutions in three key areas: Online Publishing, e-Business and Mobile Computing, we deliver connectivity – between people and applications – unlocking islands of data and knowledge. We own some of the sector’s most innovative Online Publications: PharmiWeb.com, HospitalPharma.com and Detail-Direct.com. We are actively developing solutions for Mobile Computing platforms. For example, our PharmiTabTM e-pharmacy solution runs real-time patient data and prescribing transactions in a busy hospital environment, on a TabletPC, wireless client/server platform. e-Business solutions range from e-Detailing, to Online Market Research, all designed to increase reach, increase sales, and to reduce administration and costs.


    Swiss Biotech Association

    Supporters
    http://www.swissbiotech.org/

    The Swiss Biotech Association (SBA) is the national industry association for biotechnology, including pharmaceuticals, diagnostics, agriculture, food, cosmetics, environmental biotechnology, and specialty chemicals. Members are companies active in modern biotechnology, such as R&D, Production, Marketing and Sales, Finance, Services and Consulting. SBA provides a networking platform for Life Science clusters, academic and federal institutions the like. Founded in March 1998, the Association grows steadily.


    International Pharmaceutical Industry

    Supporters
    http://www.ipimediaworld.com

    IPI gives you an insight into all areas of Biopharm, Medical, Pharmaceutical and Healthcare. IPI provides a proven supportive means of communication to the Pharmaceutical, Bio Pharmaceutical, Nutraceutical and Medical Devices industry, incorporating the latest in research and technology innovations, regulatory guidelines, marketing and communication strategies.


    pharmaphorum

    Supporters
    http://www.pharmaphorum.com

    pharmaphorum drives innovation within the pharmaceutical industry, by bringing healthcare together through a suite of media services that help produce and disseminate thought leadership, combined with an online platform for communicating messages to a global audience.Visit www.pharmaphorum.com


    Drug Discovery Today

    Supporters
    http://www.drugdiscoverytoday.com/

    Drug Discovery Today is one of the most cited review journals in the field of drug discovery, with an impact factor of 6.422.
    Drug Discovery Today will benefit your research by helping to keep you up-to-date with all of the fast-moving and emerging topics in drug discovery. Each issue is packed full of the latest research news, peer-reviewed articles and comment and opinion from leading research scientists.


    Labhoo

    Supporters
    http://www.labhoo.com



    Pharmacircle

    Supporters
    http://www.pharmacircle.com

    PharmaCircle is an innovative knowledge management company serving the current and future global leaders in the Pharmaceutical and Biotechnology related industries. PharmaCircle is a one stop information and analysis source for pipeline, products, clinical trials, drug delivery technologies, deals and acquisitions, company financials, venture capital investments, product sales, pharmaceutical services, news, patents and more….


    Bioscreening

    Supporters
    http://www.bioscreening.com



    Journal for Clinical Studies – Your Resource for Multisite Studies & Emerging Markets

    Supporters
    http://www.JforCS.com

    Published bi-monthly.JCS is a unique journal, dedicated to providing information to the global pharmaceutical, biotechnology, medical devices and contract research organisations. JCS details practical and theoretical operational procedures, challenges, validatory and regulatory guidelines when conducting trials on a multisite basis and particularly within the emerging markets, naïve patient population, and remote access areas. JCS provides country by country objectives and uniquely brings you experiences in therapeutic areas of Liver diseases, kidney diseases, insect borne diseases, malnutrition and under nutrition. JCS is led by a strong editorial advisory board sourced out for their experiences; you will get the most practical insight for your global studies. JCS invites you to join us, write for us, feature your experiences with us, advertise your capabilities with us, and ask our advisory board for suggestions and guidelines. Let us make health care available to all.


    Thomson Reuters

    Supporters
    http://thomsonreuters.com/products_services/science/

    Thomson Reuters is the leading source of intelligent information for professionals around the world. We provide essential information to keep you in touch with the rapidly-changing pharmaceutical and chemical markets, expert services to help you make informed, early decisions, and intuitive technology to manage and support your discovery and development activities. Our products give you the intelligence, tools and expertise to help you optimize your IP portfolio, monitor industry developments, identify licensing and partnering opportunities, deliver successful regulatory submissions, and support your scientific messaging, marketing, product positioning, and awareness campaigns.


    PMR

    Supporters
    http://www.pmrcorporate.com

    PMR (www.pmrcorporate.com) is a British-American company providing market information, advice and services to international businesses interested in Central and Eastern European countries as well as other emerging markets. PMR's key areas of operation include business publications (through PMR Publications), consultancy (through PMR Consulting) and market research (through PMR Research ). Being present on the market since 1995, offering high international standards in projects and publications, as well as providing one of the most frequently visited and top-ranked websites, PMR is one of the largest companies of its type in the region.


    Lab Bulletin

    Supporters
    http://www.labbulletin.com

    Lab Bulletin is a free online resource for scientists and laboratory professionals where you can catch up on the latest news for laboratory products and services. You will find an extensive directory of laboratory suppliers and manufacturers enabling you to contact companies quickly and easily to request further information. Lab Bulletin also publishes four free monthly E-Newsletters keeping you up-to-date with all of the latest laboratory products and industry news directly to your inbox. We have dedicated E-Newsletters for Chromatography and Spectroscopy, Microscopy and Image Analysis, weekly Industry News updates and our monthly Lab Bulletin E-Newsletter sent out to over 29,000 readers worldwide. To request your free copy click here


    Drug Discovery World

    Supporters
    http://www.ddw-online.com

    For over a decade DDW has continued to be the ‘must read’ journal within the DD&D Arena. DDW is recognised for voicing the opinions of some of the Industry’s leading luminaries and has become a recognised platform for Industry Gurus to debate some of the more challenging technological and business issues facing the the life science industry. DDW adheres to the maxim..... ‘Turning Science into Business’ DDW examines the advances in new technologies and the associated implications within the context of developing new and efficacious therapeutics. DDW is distinguishable in that it reaches out to a global audience at both bench and boardroom level, allowing both camps to profit from the uncomplicated style of editorial but at the same time challenges our readers to look at new ways to overcome discovery bottlenecks, embrace nascent technologies and build next generation technology platforms.


    Biosave

    Supporters
    http://www.Biosave.com

    Biosave.com brings together the best Life Science promotions, product releases, featured products, publications, videos and events from 100’s of leading Life Science suppliers. Updated 24 hours a day, Biosave is constantly uploading special promotions and exciting product news that you won’t find anywhere else. Our goal is to provide our users with the most exclusive product information to help reach that all important purchasing decision.

    Holiday Inn Regents Park

    Carburton Street
    London W1W 5EE
    United Kingdom

    Holiday Inn Regents Park

    Choose the well-connected Holiday Inn London-Regent's Park hotel, with a superb central London location and speedy transport links. Holiday Inn London-Regent's Park is in a leafy and cosmopolitan area of central London, a 10-minute walk from bustling Oxford Street. Leave your car in our NCP managed underground car park, and explore London by Tube. Great Portland Street Tube station is 25 metres from the hotel, from where you can reach the City and Canary Wharf in 30 minutes, and London Heathrow Airport in 45 minutes.

    Wireless Internet is available throughout the hotel, and you can invite up to 300 people to events at the Academy Conference Centre, with an IT technician and break-out zones. Holiday Inn London-Regent's Park is a 10-minute walk from Santander's offices and businesses in the BT Tower. Stroll 5 minutes to Regent's Park, where you'll find London Zoo and pretty Primrose Hill. We're a 10-minute walk from Bond Street boutiques and 20 minutes from Buckingham Palace and cruises on the River Thames.

    Ask our Concierge to plan your day out and book West End theatre tickets. Room Service is available 24 hours at Holiday Inn London-Regent's Park, or dine in the vibrant Junction Restaurant. Our Junction Bar has a menu of light bites, and a hot breakfast buffet is served daily.

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SMi GROUP LTD

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SMi Group Ltd, 1 Westminster Bridge Road, London, SE1 7XW, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
    Registered in England No: 3779287 VAT No: GB 976 2951 71




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.